Preliminary evaluation of a monovalent antivenom targeting Cerastes cerastes envenomation in North Africa: feasibility and specificity assessment
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
In 2017, the World Health Organization (WHO) recognized snakebite envenomation as a neglected disease yet the therapeutic effectiveness efficacy of available antivenoms remains insufficiently explored. This study offers a detailed analysis of Cerastes cerastes venom, focusing its toxicological properties and the development of specific targeted neutralizing antibodies. Through rigorous quality control and comprehensive efficacy testing, the antivenom demonstrated significant neutralizing activity against critical venom components, including hemorrhagic, edema-forming, and myotoxic effects while also mitigating tissue damage. Histological investigations further corroborated the antivenom’s protective capacity. These findings not only underscore the potential of the developed antivenom for clinical use but also provide essential insights for advancing antivenom production, refining its specificity, and enhancing its therapeutic efficacy in managing snake envenomations.
Fields of Study & Subjects
Venomous Animal Envenomation and Studies
Amphibian and Reptile Biology
Healthcare and Venom Research
Publication details
- Journal / source
- Frontiers in Pharmacology
- Volume
- 17
- Pages
- 1719611–1719611
- Publication date
- 26 March 2026
- Language
- EN